Extravasation injuries: implications for WOC nursing.
Froiland
Kathy
K
GlaxoSmithKline, 200 North 16th Street, Philadelphia, PA 19102, USA. Kathryn.froiland@gsk.com
D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007509:Irritants / Q000009:adverse effects; D009720:Nurse Clinicians / Q000458:organization & administration; D024802:Nurse's Role; D009730:Nursing Assessment; D011322:Primary Prevention / Q000379:methods; D012307:Risk Factors; D017592:Skin Care / Q000379:methods* / Q000451:nursing
D007509:Irritants